key: cord-0294331-rxw3qigj
authors: Lei, Ruipeng; Tan, Timothy J.C.; Garcia, Andrea Hernandez; Wang, Yiquan; Teo, Chuyun; Gopan, Gopika; Dargani, Zahra Tavakoli; Teo, Qi Wen; Graham, Claire S.; Nair, Satish K.; Wu, Nicholas C.
title: Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase
date: 2022-02-24
journal: bioRxiv
DOI: 10.1101/2022.02.24.481718
sha: e32b1d494e5cfcafd4b1afeb35bdcdb074ca7528
doc_id: 294331
cord_uid: rxw3qigj

Neuraminidase (NA) of human influenza H3N2 virus has evolved rapidly and been accumulating mutations for more than half-century. However, biophysical constraints that govern the evolutionary trajectories of NA remain largely elusive. Here, we show that among 70 natural mutations that are present in the NA of a recent human H3N2 strain, >10% are deleterious for an ancestral strain. By mapping the permissive mutations using combinatorial mutagenesis and next-generation sequencing, an extensive epistatic network is revealed. Biophysical and structural analyses further demonstrate that certain epistatic interactions can be explained by non-additive stability effect, which in turn modulates membrane trafficking and enzymatic activity of NA. Additionally, our results suggest that other biophysical mechanisms also contribute to epistasis in NA evolution. Overall, these findings not only provide mechanistic insights into the evolution of human influenza NA and elucidate its sequence-structure-function relationship, but also have important implications for the development of next-generation influenza vaccines.

mutations that are present in the NA of a recent human H3N2 strain, >10% are deleterious for an 23 ancestral strain. By mapping the permissive mutations using combinatorial mutagenesis and next-24 generation sequencing, an extensive epistatic network is revealed. Biophysical and structural 25 analyses further demonstrate that certain epistatic interactions can be explained by non-additive 26 stability effect, which in turn modulates membrane trafficking and enzymatic activity of NA. 27

Additionally, our results suggest that other biophysical mechanisms also contribute to epistasis in 28 NA evolution. Overall, these findings not only provide mechanistic insights into the evolution of 29 human influenza NA and elucidate its sequence-structure-function relationship, but also have 30 important implications for the development of next-generation influenza vaccines.

Influenza A virus, which causes around 300,000 to 650,000 deaths yearly over the world (Iuliano 33 et al., 2018) , continues to be a major global health concern. Influenza A virus has two surface 34 glycoproteins, hemagglutinin (HA) and neuraminidase (NA), that act as the major antigens. 35

Because of the need to constantly escape from herd immunity, both HA and NA of human 36 influenza A virus evolve rapidly. Most studies on the evolution of human influenza A virus focus 37 on HA, due to its dominant role in vaccine development (Wu and Wilson, 2017 Mechanisms of epistasis can be categorized into two classes, specific and non-specific (Starr and 57 Thornton, 2016). Specific epistasis, which describes a nonlinear mapping from sequence to 58 physical property, typically involves mutations that are spatially proximal on the protein structure 59 and physically interacting with each other. In contrast, non-specific epistasis, which describes a 60 nonlinear mapping from physical property to phenotype, depends less on the spatial distance 61 between mutations. Both types of epistasis are involved in the natural evolution of human 62 influenza virus. For example, specific epistasis is observed in a network of HA mutations that 63 coordinately modulate the evolution of receptor-binding mode (Wu et al., 2018 (Wu et al., , 2020 . On the 64 other hand, non-specific epistasis is observed in the evolution of influenza nucleoprotein (NP), in 65 which the emergence of destabilizing mutations is contingent on the presence of stabilizing 66 mutations to maintain a melting temperature of at least 43 °C for optimum transcriptional activity 67 (Gong et al., 2013) . As a result, characterization of epistasis can provide mechanistic insights into 68 the biophysical constraints that govern the evolutionary trajectories of influenza proteins (Wu et 69 al., 2018) . 70

In this study, we systematically identified natural mutations in human H3N2 NA that were unfit in 72 an ancestral strain but subsequently emerge. We further mapped an epistatic network among natural mutations in human H3N2 NA using combinatorial mutagenesis and next-generation 74 to the difference in HA, as replacing the HK68 HA with Vic11 HA did not affect the WT virus titer 95 ( Figure S2) Figure 1C ). This observation indicates that the permissive mutations for N387K emerged 105 between 1993 and 2003. Similarly, our result implies that the permissive mutations for N336H 106 emerged between 1969 and 1971, since mutating residue 336 to His was neutral in Bil71 and 107

Alb76 but reduced the virus titer of Bil69 to below the detection limit ( Figure 1D) . 108

In fact, the double mutant K385N/N387K in Mos99 yielded a WT-like titer (Figure 2B) , 116 demonstrating that K385N was a permissive mutation for N387K. Of note, K385N alone was 117 neutral to the Mos99 ( Figure S3) . Nevertheless, mutating residue 385 to Asn could not restore 118 the fitness of N387K in earlier strains, including HK68, Bk79, Bei89, and SD93 (Figure 2B) , 119 suggesting that additional permissive mutations are required for the natural emergence of N387K. 120 121

Although N387K decreased the fitness of Mos99, it reduced the titer of SD93 to below the 123 detection limit ( Figure 1C) . As a result, the difference in the NA sequences between SD93 and 124

Mos99 should include additional permissive mutations for N387K. The NA head domains of SD93 125 and Mos99 differed by 18 mutations (Figure S1C ). Since multiple mutations may be required 126 simultaneously to restore the fitness of N387K in SD93, we have decided to use a high-throughput 127 approach that coupled combinatorial mutagenesis and next-generation sequencing (Wang et al., 128 2021; Wu et al., 2018 Wu et al., , 2020 to identify permissive mutations for N387K. Briefly, we constructed 129 a mutant library for SD93 that contained all possible combinations of 10 mutations (n = 2 10 = 1024 130 variants), namely E248G, R249K, I265T, Y336H, R338L, N339D, K344E, S346G, E369K, and 131 G381E (Figure 2C ), in the genetic background of N387K. Those 10 mutations were selected 132 based on their distances to N387K in the protein structure and the primary sequence. The viral 133 mutant library was then rescued and passaged once in MDCK-SIAT1 cells, which could minimize 134 the emergence of cell-adaptive mutation (Tamura et al., 2013) . Mutations E248G, R249K, Y336N, 135 K344E, and E369K were enriched among variants with a frequency of >0.1% in the post-passaged mutant libraries of both biological replicates (Figure 2D) , suggesting that they could 137 restore the fitness of N387K in SD93. Of note, Y336N was not included in the construction of the 138 mutant library, and hence a de novo mutation that emerged during viral passaging. Interestingly, 139 Y336N represented a reversion to the ancestral stain HK68 (Figure S1A) . 140

To validate the findings from our high-throughput screening, we performed a series of virus rescue 142 experiments with individually constructed SD93 mutants ( Figure 2E ). The pentamutant 143 E248G/R249K/Y336N/K344E/E369K was indeed able to partially restore the fitness of N387K. 144

The fitness of E248G/R249K/Y336N/K344E/E369K/N387K could be further increased by the 145 addition of K385N. There seemed to be a synergistic effect among these permissive mutations, 146 because none of E248G/R249K, Y336N, K344E, E369K, and K385N alone could restore the 147 fitness of N387K to a detectable level (Figure 2B and E) . We also tested whether Y336H, which 148 was a mutation in our mutant library, instead of Y336N, which was a de novo mutation that 149 emerged during passaging of the mutant library (see above), could act as a permissive mutation 150 for N387K. However, both Y336H alone and the pentamutant 151 E248G/R249K/Y336H/K344E/E369K could not restore the fitness of N387K ( Figure 2E) 

Besides N387K, N336H was another highly deleterious mutation in earlier strains (Figure 1D) , 158 and yet emerged during the evolution of human H3N2 NA. Mutations between the NA head 159 domains of Bil69 and Bil71 were identified as candidate permissive mutations for N336H ( Figure  160 S1D), since these two strains have drastically different compatibility with His336 ( Figure 1D) . In 161 particular, we focused on eight mutations that were spatially proximal to residue 336, namely 162 R249K, D286G, I302V, M307V, D329N, K334S, N356D, and L370S ( Figure 3A) . To identify which 163 of these eight mutations were permissive mutations for N336H, we used the same high-164 throughput approach that was described above. Our Bil69 mutant library contained all possible 165 combinations of the eight mutations of interest (n = 2 8 = 256 variants), in the background of N336H. 166

Among variants that were enriched by at least 2-fold in the post-passaged mutant libraries of both 167 biological replicates, N356D was highly conserved ( Figure 3B ). Our virus rescue experiment 168 further validated that N356D was a permissive mutation for N336H and was neutral when being 169 introduced alone ( Figure 3C) . While N336H represented a mutation from HK68 to Vic11, Bil71 170 has a Tyr at residue 336 ( Figure S1D ). Same as N336H, N336Y also reduced the titer of Bil69 to 171 below the detection limit and N356D could restore it to the WT level ( Figure 3C ). These results 172

show that N356D is a permissive mutation for the natural evolution of residue 336, which in turn 173 participates in a more extensive epistatic network that involve N387K (Figure 2D-E) . 174 175 Enzymatic activities of H3N2 NA mutants 176

To understand the mechanisms of epistasis that involved N336H/Y and N387K, we first measured 177 the NA activities on the surface of cells that were transiently transfected with different NA mutants.

N387K drastically reduced the cell surface NA activity of Mos99 and SD93 ( Figure 4A-B) , 179 whereas both N336H and N336Y abolished the cell surface NA activity of Bil69 ( Figure 4C) . The 180 reduced cell surface NA activity of N387K in Mos99 and SD93 could be partially restored by 181 K385N and E248G/R249K/Y336N/K344E/E369K, respectively (Figure 4A-B) . Similarly, the 182 reduced cell surface NA activity of N336H and N336Y in Bil69 could be fully restored by N356D 183 ( Figure 4C) . Therefore, the cell surface NA activities of different mutants were largely consistent 184 with their effects on virus replication fitness (Figures 2B, 2E and 3C) . In contrast to N387K, N336H did not reduce the Tm of Bil69 NA. However, the first differential 215 curve of the thermal shift assay for Bil69 N336H had an atypical shape ( Figure S5) . Similarly, the 216 first differential curve for Bil69 N336Y showed two peaks. These results indicate the presence of 217 multiple oligomeric states, hence aggregations (Gao et al., 2020) . The shapes of their first 218 differential curves returned to WT-like when N356D was introduced. As a result, the biophysical 219 basis of epistasis between K385N and N387K is different from that between N336H/Y and N356D.

We further aimed to examine the structural mechanism of epistasis between K385N and N387K. 222

We determined the crystal structure of NAs from Bil69, SD93, and Mos99 to 1.54 Å, 1.65 Å, and 223 1.40 Å, respectively (Table S1) recover-R were used as primers (Table S2) . For Bil69 mutant library, Bil69lib-recover-F and 365

Bil69lib-recover-R were used as primers (Table S3) (1) 381 A pseudocount of 1 was added to the read counts to avoid division by zero in subsequent steps. 382

Subsequently, the enrichment of mutant was computed for each replicate as follows: 383

(2) 384

Bil69 mutants with a read count of less than 10 in the plasmid mutant library were discarded. For 385 SD93 mutant library, the frequency of each mutant was calculated using the same method, except 386 that the pseudocount was not added. 387

The NA head domains, which contain residues 82 to 469, were fused to an N-terminal gp67 signal 390 peptide, 6×His-tag, a vasodilator-stimulated phosphoprotein (VASP) tetramerization domain, and 391 a thrombin cleavage site. Recombinant bacmid DNA that carried the NA ectodomain from the 392 strain of interest was generated using the Bac-to-Bac system (Thermo Fisher Scientific). Phenix suite (Adams et al., 2010) , using as PDB 2AEP as the replacement model (Venkatramani 516 et al., 2006) . The structure was further refined using REFMAC5 (Murshudov et al., 2011) and was 517 manually built in COOT (Emsley et al., 2010) . Ramachandran statistics were calculated using 518

MolProbity (Chen et al., 2010) . 519 520

The steady-state tryptophan emission spectra were measured using a fluorometer (FP8300, 522 JASCO). Samples for the emission spectra measurements were prepared by diluting the protein 523 stock in SEC buffer (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 mM CaCl2) to an OD280 = 0. 

Role of permissive neuraminidase 638 mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses

PHENIX: a comprehensive Python-641 based system for macromolecular structure solution

Location of antigenic 644 sites on the three-dimensional structure of the influenza N2 virus neuraminidase

Permissive secondary mutations enable the 647 evolution of influenza oseltamivir resistance

A guided tour into subcellular colocalization analysis in 649 light microscopy

MolProbity: all-atom structure validation for 652 macromolecular crystallography

Biopython: freely available Python tools for 655 computational molecular biology and bioinformatics

Structure of the catalytic and antigenic 657 sites in influenza virus neuraminidase

Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. 660

Antibody correlates and predictors of immunity to naturally occurring influenza in 663 humans and the importance of antibody to the neuraminidase

Tetrameric neuraminidase 665 of influenza A virus is required to induce protective antibody responses in mice

Epistatic interactions between neuraminidase mutations facilitated 669 the emergence of the oseltamivir-resistant H1N1 influenza viruses

Neuraminidase, the forgotten surface antigen, 671 emerges as an influenza vaccine target for broadened protection

Features and development of Coot

Design of the recombinant influenza neuraminidase antigen is crucial for 676 its biochemical properties and protective efficacy

Theory and applications of differential scanning 678 fluorimetry in early-stage drug discovery

Stability-mediated epistasis constrains the 680 evolution of an influenza protein

A sulfonozanamivir analogue has potent anti-influenza virus activity

Structure-based design of prefusion-stabilized SARS-686 CoV-2 spikes

Estimates of global seasonal influenza-689 associated respiratory mortality: a modelling study

NAction! How can 692 neuraminidase-based immunity contribute to better influenza virus vaccines? mBio 9

A highly stable 695 prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Mutation and epistasis in influenza virus evolution

Influenza virus neuraminidase structure and functions

Evaluation of antihemagglutinin and antineuraminidase 703 antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge 704 model

How mutational epistasis impairs predictability in protein 706 evolution and design

Antibody to influenza virus neuraminidase: an independent correlate of 709 protection

REFMAC5 for the refinement of macromolecular crystal 712 structures

Generation of influenza A viruses entirely from cloned 715 cDNAs

Immunogenicity and structures of a rationally 718 designed prefusion MERS-CoV spike antigen

Steps in maturation of influenza A virus 720 neuraminidase

Virus vaccines: proteins prefer prolines

A next-generation cleaved, soluble HIV-1 Env trimer

664 gp140, expresses multiple epitopes for broadly neutralizing but not non-726 neutralizing antibodies

Epistasis and the adaptability of an 728 RNA virus

Broadly protective human antibodies that 731 target the active site of influenza virus neuraminidase

Epistasis in protein evolution

A novel recombinant influenza virus neuraminidase vaccine 736 candidate stabilized by a measles virus phosphoprotein tetramerization domain provides robust 737 protection from virus challenge in the mouse model

Cell culture-selected substitutions in influenza 740 A(H3N2) neuraminidase affect drug susceptibility assessment

Structural and functional analysis of laninamivir and its octanoate prodrug reveals group 744 specific mechanisms for influenza NA inhibition

An epidemiologically significant epitope of a 1998 human influenza virus 747 neuraminidase forms a highly hydrated interface in the NA-antibody complex

Data processing and analysis with the autoPROC toolbox

The neuraminidase of A(H3N2) influenza viruses circulating since 2016 754 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain

Antigenic evolution of human 757 influenza H3N2 neuraminidase is constrained by charge balancing

Neutralizing and neuraminidase antibodies correlate 760 with protection against influenza during a late season A/H3N2 outbreak among unvaccinated 761 military recruits

A perspective on the structural and functional constraints for 763 immune evasion: insights from influenza virus

A complex epistatic network limits the mutational reversibility in the 766 influenza hemagglutinin receptor-binding site

Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness 769 landscape

PEAR: a fast and accurate Illumina 771 Paired-End reAd mergeR

Influenza 773 virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors

Structural basis of protection against H7N9 influenza virus 777 by human anti-N9 neuraminidase antibodies